Hypermarcas (OTCMKTS:HYPMY) Share Price Crosses Above 50 Day Moving Average – Should You Sell?

Shares of Hypermarcas (OTCMKTS:HYPMY) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $4.29 and traded as high as $4.93. Hypermarcas shares last traded at $4.93, with a volume of 1,691 shares trading hands.

Analysts Set New Price Targets

Separately, Scotiabank raised Hypermarcas to a “strong-buy” rating in a research note on Thursday, July 17th. One research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.

Hypermarcas Trading Up 4.7%

The business’s fifty day moving average is $4.29 and its 200 day moving average is $4.42. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of 23.48 and a beta of 0.82. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.